Vulcan Energy Gains 14% as Lithium Peers Recover, While Two Bank Disclosures Reshape the Register

Published on 10/26/2026 at 13:41 | Editorial boerse-global.de

Vulcan Energy stock gained 14% amid a broader lithium sector rally, with no new company announcement; quarterly report due 28 October.

Vulcan Energy Illustration mit AI erstellt.

Vulcan Energy shares climbed 14% on Monday, catching the same updraft lifting Australian lithium names more broadly, with PLS Group and Liontown also advancing on media reports. The stock last stood at EUR 0.7515. No fresh company announcement accompanied the move beyond voting-rights notifications from major holders already in the public domain.

That distinction matters. The rally is a sector-wide affair, not a response to corporate news. The stock had finished Friday down 5.6%.

Custody Filings, Not Strategic Bets

The register has seen two separate disclosure updates within roughly a week. JPMorgan Chase & Co. reported an increase in its disclosed voting stake to 6.98% from 5.38%, while Citigroup lifted its own from 9.6615% to 11.3823%.

Should investors sell immediately? Or is it worth buying Vulcan Energy?

Both filings carry a caveat that investors should keep in view: they reflect voting rights, not necessarily a matching increase in directly held shares. Securities lending arrangements feature in each notification, alongside purchases and sales executed for the banks' own account. Citigroup's filing further describes market contracts entered into in the ordinary course of business — not a declared strategic investment. The gap between a reported voting position and outright economic ownership is spelled out in the disclosures themselves.

Lionheart: Reagent Production and a Reinjection Test

On the operational side, Vulcan has begun commercial-scale manufacturing in Germany of VULSORB, its proprietary lithium extraction agent. The production campaign is intended to supply the initial fill of the extraction columns at Lionheart, with commissioning of that facility scheduled for the second half of 2028. The announcement covers the making of the reagent; startup of the plant itself remains a planned future step.

Roughly two weeks earlier, the company reported a successful test at well LSC-3a, in which lithium-lean brine was reinjected into the reservoir's sandstone matrix. Management said the result confirmed a central assumption of the Lionheart production plan and reduced risks in the field development programme, strengthening confidence in its execution. Vulcan added that the findings will feed into the design of subsequent reinjection wells. The assessment is the company's own.